Administrative, Leadership Development and Advocacy Core

核心A：摘要 前列腺癌的孢子汇集了一个高度积极的多学科研究团队， 西北大学和芝加哥大学，北岸大学提供捐助 HealthSystem（UC附属公司）。该团队包括实验室科学家，泌尿科医生，医学肿瘤学家， 病理学家、生物统计学家和生物信息学家，他们都致力于进行最先进的 转化研究，以开发和测试干预措施，改善患者的诊断结果， 前列腺癌 行政、领导力发展和宣传核心有以下具体目标： 具体目标1：提供SPORE内的集成，并与Robert H. Lurie综合癌症 中心和芝加哥大学综合癌症中心 具体目标2：对研究项目和核心项目进行强有力的监督，并通过以下方式进行财务监督： 规划和评价活动 具体目标3：监督以下机构的发展研究和职业发展计划： SPORE鼓励研究人员进行转化前列腺癌研究 具体目标4：在社区领导倡导小组和多样性教育倡议 具体目标5：培养前列腺癌研究的下一代领导者 具体目标6：促进与NIH和其他国家资助项目的合作和整合， 作为U54 CA203000（芝加哥合作促进和推进癌症健康公平），部门 国防和前列腺癌基金会。

CORE A: ABSTRACT The SPORE in Prostate Cancer brings together a highly motivated multidisciplinary team of investigators from Northwestern University and the University of Chicago, with contributions from NorthShore University HealthSystem (UC affiliate). The team includes laboratory scientists, urologists, medical oncologists, pathologists, biostatisticians and bioinformaticians, all of whom are dedicated to conducting state-of-the-art translational research to develop and test interventions that improve the outcome of patients diagnosed with prostate cancer. The Administrative, Leadership Development and Advocacy Core has the following Specific Aims: Specific Aim 1: To provide integration within the SPORE, and with the Robert H. Lurie Comprehensive Cancer Center and the University of Chicago Comprehensive Cancer Center Specific Aim 2: To provide strong oversight of research projects and cores as well as financial oversight through planning and evaluation activities Specific Aim 3: To oversee the Developmental Research (DRP) and Career Enhancement (CEP) Programs of the SPORE to encourage investigators to conduct translational prostate cancer research Specific Aim 4: To lead an advocacy group and diversity education initiatives in the community Specific Aim 5: To train the next generation of leaders in prostate cancer research Specific Aim 6: To facilitate collaborations and integration with NIH and other nationally funded programs such as the U54 CA203000 (The Chicago Collaborative to Promote and Advance Cancer Health Equity), Department of Defense and Prostate Cancer Foundation.